Amber-date mind-tranquilizing capsule and preparation method thereof

Abstract

The invention discloses an amber-date mind-tranquilizing capsule and a preparation method thereof. The amber-date mind-tranquilizing capsule contains the following components in parts by weight: 12-18parts of dried longan pulp, 18-22 parts of tuber fleeceflower stem, 12-18 parts of tartary buckwheat, 10-15 parts of salvia miltiorrhiza, 3-6 parts of amber, 10-15 parts of poria with hostwood, 8-10parts of bighead atractylodes rhizome, 12-18 parts of spina date seed, 8-12 parts of platycodon grandiflorum, 8-12 parts of polygala tenuifolia, 8-12 parts of schisandra chinensis, 3-6 parts of radixaucklandiae, 12-18 parts of radix paeoniae rubra, 10-15 parts of radix bupleuri, 10-15 parts of angelica sinensis, 8-10 parts of fresh ginger, 8-10 parts of pinellia ternata, 10-15 parts of semen perillae acutae, 15-20 parts of rhizoma cyperi, 8-12 parts of liquorice, 2-5 parts of coptis chinensis, and 3-5 parts of pericarpium citri reticulatae. The obtained traditional Chinese medicine composition has the efficacies of tranquilizing mind and diffusing the lung, reducing phlegm and strengthening will, activating blood and the like, and is mainly used for treating insomnia caused by phlegm-firedisturbing heart and heart-blood deficiency, including symptoms of insomnia and depression caused by upset and palpitation, choking sensation in chest and amnesia. The capsule is simple in preparation, convenient to take and free from toxic or side effect.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a Huzao Ningshen capsule and a preparation method thereof. Background technique [0002] Insomnia belongs to the insomnia of modern medicine, and it is one of the most prevalent sleep disorders in modern society. Due to the different diagnostic criteria, the reported epidemiological data vary greatly, ranging from about 10% to 50%. [0003] Modern medicine treatment primary disease measure has: (1) based on sedative hypnotics, more commonly used have benzodiazepines and non-benzodiazepines hypnotics. The American Sleep Disorders Association once recommended non-benzodiazepine hypnotic drugs as the drug of choice for primary insomnia, and suggested the principles of "on-demand medication" and "intermittent medication", but there is no mature intermittent treatment model at present, and There is no drug that fully meets the requirements of an ideal hypnotic. (2) Other...

AI Technical Summary

Problems solved by technology

However, these two drugs have no dependence and can effectively treat anxiety, depression and withdrawal symptoms after dependence on benzodiazepines

(3) Non-drug therapy mainly includes cognitive-behavioral therapy and various physical therapies. These treatments have basically no side effects and addiction, and the long-term effect is better, but the onset is slow, and requires the cooperation of professionals and patients, which is costly. More manpower and time, etc.

[0004] Although Western medicine has quick onset and strong effects in treating insomnia, it has certain side effects or potential addiction, and some medicines are expensive or unstable in curative effect. Significantly improve the sleep time and quality of patients, only mild or non-addictive, mild adverse reactions, not easy to relapse, etc., and gradually become the first choice for the treatment of insomnia